Quince Therapeutics (NASDAQ:QNCX – Free Report) had its target price cut by D. Boral Capital from $12.00 to $4.00 in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback